PriceTarget Research
  • Home
  • Videos
  • Rating Reports
  • Scorecards
  • Alerts
  • Our Stock Rankings
  • About Us
  • Contact Us
HomeratingsA

rating: A

Price Chg

Alert: Major Price Decline (3/21/24)-The Bancorp Inc (NASDAQ: TBBK).

March 21, 2024 John Lafferty 0

The Bancorp Inc (NASDAQ: TBBK) stock suffered a major decline of -10.2% on 3/21/24. The shares closed at $32.12. Moreover, trading volume in this decline was exceptionally high at 563% of normal. The stock has […]

New Earnings

Alert: New Earnings Report (3/21/24)-Shoe Carnival Inc (NASDAQ: SCVL).

March 21, 2024 John Lafferty 0

Shoe Carnival Inc (NASDAQ: SCVL) has reported earnings for its fourth fiscal quarter (ending January 31) of $0.57 versus $0.80 for the same period a year ago. E.P.S. were $2.69 for the latest four quarters […]

New Earnings

Alert: New Earnings Report (3/21/24)-Winnebago Industries Inc. (NYSE: WGO).

March 21, 2024 John Lafferty 0

Winnebago Industries Inc. (NYSE: WGO) has reported E.P.S. of $-0.43 for its second fiscal quarter (ending February 28) versus $1.73 for the same period a year ago. For the latest four quarters through February 28, […]

Reports

Rating Update: Stock Rating A-Highest (3/21/24)-M.D.C. Holdings Inc. (MDC).

March 21, 2024 John Lafferty 0

BUSINESS M.D.C. Holdings, Inc., through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes […]

Negative

Alert: Negative Investment/Fundamental Signals (3/21/24)-JAKKS Pacific Inc (NASDAQ: JAKK)

March 21, 2024 John Lafferty 0

Recent extremely meaningful negative changes in investment behavior have impacted JAKKS Pacific Inc (NASDAQ: JAKK): the stock’s recent price decline challenged its longer term uptrend, and negative upside/downside volume developed. JAKKS Pacific Inc (NASDAQ: JAKK) […]

Reports

Rating Update: Stock Rating A-Highest (3/20/24)-Catalyst Pharmaceutical Inc (CPRX).

March 20, 2024 John Lafferty 0

BUSINESS Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets […]

signals-pos

Alert: Positive Investment/Fundamental Signals (3/20/24)-Tenaris SA (NYSE: TS)

March 20, 2024 John Lafferty 0

Tenaris SA (NYSE: TS) has recently enjoyed meaningful positive changes in fundamentals: the consensus estimate for December, 2024 increased significantly, significant quarterly sales acceleration occurred, and the consensus estimate for December, 2025 increased significantly. Tenaris […]

Reports

Rating Update: Stock Rating A-Highest (3/20/24)-Mizuho Financial Group Inc (MFG).

March 20, 2024 John Lafferty 0

BUSINESS Mizuho Financial Group, Inc., together with its subsidiaries, engages in banking, trust, securities, and other businesses related to financial services in Japan, the Americas, Europe, Asia/Oceania, and internationally. It operates through five segments: Retail […]

Reports

Rating Update: Stock Rating A-Highest (3/20/24)-Sally Beauty Holdings Inc (SBH).

March 20, 2024 John Lafferty 0

BUSINESS Sally Beauty Holdings, Inc. operates as a specialty retailer and distributor of professional beauty supplies. The company operates through two segments, Sally Beauty Supply (SBS) and Beauty Systems Group (BSG). The SBS segment offers […]

Price Chg

Alert: Major Price Advance (3/20/24)-First Foundation Inc (NYSE: FFWM).

March 20, 2024 John Lafferty 0

First Foundation Inc (NYSE: FFWM) stock enjoyed a major increase of 10.6% on 3/20/24. The shares closed at $7.30. This advance was accompanied by normal trading volume. The stock has declined -8.7% during the last […]

Posts navigation

« 1 … 194 195 196 … 251 »

Search

Ratings

  • A
  • B
  • C
  • D
  • F

Exchanges

  • NASDAQ
  • NYSE
  • NYSEAMERICAN
  • CVE
  • BATS
  • TSE
  • NYSEARCA

Industries

Sectors

Privacy Statement Terms Of Use ©2024 PriceTarget Research